Skip to main content
Clinical Trials/NCT01139801
NCT01139801
Completed
Not Applicable

Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon

Aultman Health Foundation1 site in 1 country50 target enrollmentSeptember 2009

Overview

Phase
Not Applicable
Intervention
Oxytocin
Conditions
Induction of Labor
Sponsor
Aultman Health Foundation
Enrollment
50
Locations
1
Primary Endpoint
Rate of Induction To Delivery
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to specifically investigate the efficacy of an alternative pharmacologic cervical ripening agent, misoprostol, versus the standard oxytocin, as an adjunct to Foley balloon for induction of the unfavorable cervix.

Detailed Description

The design of this study is a randomized, controlled study with two arms. Both groups will undergo placement of a Foley catheter, through the external and internal os of the cervix, according to standard practice. In group A, receiving intravenous infusion of oxytocin, will serve as the control group as it is standard protocol at Aultman Hospital. Group B, intravaginal placement of misoprostol, will serve as the experimental group. The expected duration of participation begins at induction of labor and concludes at time of delivery.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
March 2010
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participant or surrogate is capable of giving informed consent
  • Anticipated number - 50 patients with 25 in each study arm Female with singleton gestation, live intrauterine pregnancy
  • Participant is undergoing an indicated induction of labor
  • Participant is found to have cervical Bishop score ≤5 on initial cervical exam
  • Participant has no medical or obstetrical contraindications to induction of labor

Exclusion Criteria

  • Participant has ≥2 painful contractions in 10 min in 2 subsequent 10 min periods
  • Manufacturer's contraindications to misoprostol or oxytocin

Arms & Interventions

Oxytocin

Foley balloon placement with intravenous low dose oxytocin administration starting 2 milliunits per minute.

Intervention: Oxytocin

Misoprostol

Misoprostol, 25 mcg, is placed intravaginally into the posterior fornix of the vagina in conjunction with Foley balloon placement

Intervention: Misoprostol

Outcomes

Primary Outcomes

Rate of Induction To Delivery

Time Frame: 24 hrs

To assess effectiveness of misoprostol used in conjunction with Foley balloon versus the standard oxytocin regimen in regards to induction times

Secondary Outcomes

  • Delivery Route(24 hrs)

Study Sites (1)

Loading locations...

Similar Trials